Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Comment by 1ottrunneron Jun 04, 2021 6:33am
160 Views
Post# 33328125

RE:Good Friday Morning ! Interesting Read !!

RE:Good Friday Morning ! Interesting Read !!

It's very close to being over, weeks away.

Pfizer have just completed a trial using an oral medication, that news dropped yesterday.

https://www.news-medical.net/news/20210602/HydroxychloroquineAzithromycin-therapy-at-a-higher-dose-improved-survival-by-nearly-20025-in-ventilated-COVID-patients.aspx

The trial listing is here

https://clinicaltrials.gov/ct2/show/NCT04381962?term=pfizer&cond=Covid19&draw=6&rank=45
the UCSF version (YES THAT UCSF)
https://clinicaltrials.gov/ct2/show/NCT04332107?term=pfizer&cond=Covid19&draw=7&rank=57

Pfizer also has this trial of an oral medication due to complete last month, phase 2, if updated to phase 3 may very well coe with eua.

https://clinicaltrials.gov/ct2/show/NCT04366050?term=pfizer&cond=Covid19&draw=6&rank=47
and
https://clinicaltrials.gov/ct2/show/NCT04366050?term=pfizer&cond=Covid19&draw=7&rank=51


 

<< Previous
Bullboard Posts
Next >>